Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to CyclophosphamideAtefeh Khodakarami, Farhad Jadidi‐Niaragh, Ali Masjedi et al.|Cell Communication and Signaling|2023Cited by 16
The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemiaShiva Abolhasani, Farhad Jadidi‐Niaragh, Seyyed Sina Hejazian et al.|IUBMB Life|2022Cited by 7
Cover ImageShiva Abolhasani, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi et al.|IUBMB Life|2023Cited by 0